Legend Biotech Corporation (NASDAQ:LEGN), with a market capitalization of $6.74 billion, has emerged as a prominent player in the biotechnology sector, primarily due to the success of its flagship ...

Enhanc3D Genomics launched a suite of 3D multi-omics solutions to accelerate drug development during a presentation at last ...

Polyethylene terephthalate (PET) is one of the most widely used plastics, commonly found in bottles, fibers, and many other ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

CRANBURY, NEW JERSEY / ACCESS Newswire / January 28, 2025 / AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process de ...

Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Investors continue to flock to pharma services, targeting opportunities across the range of providers to the ...

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

In the third and last installment of this mini-series, we will hear from two science-focused majors who found unique ways, ...